← SynDRA
BUTACLAMOL
SynDRA canonical compound SYN0000290 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | DRD1 | DRD2 | DRD3 | DRD4 | DRD5 | HTR1A | HTR2A |
|---|
| Mechanism of action | dopamine receptor antagonist |
|---|
All known targets
- DRD1
- DRD2
- DRD3
- ADORA3
- DRD4
- DRD5
- HTR1A
- HTR2A
Mechanisms of action (all sources)
- dopamine receptor antagonist
- DRD3 INHIBITOR
- DRD2 INHIBITOR
- DRD1 INHIBITOR
- ADORA3 INHIBITOR
Cross-references
Synonyms
- (+)-BUTACLAMOL
- d-Butaclamol
- CHEMBL8514
- 1H-Benzo(6,7)cyclohepta(1,2,3-de)pyrido(2,1-a)isoquinolin-3-ol, 2,3,4,4a,8,9,13b,14-octahydro-3-(1,1-dimethylethyl)-, (3S-(3-alpha,4a-alpha,13b-beta))-
- (+/-)-Butaclamol hydrochloride
- BUTACLAMOL,d-
- AC1L1XRQ
- BUTACLAMOL,(+)
- GTPL62
- BUTACLAMOL, (-)
- Biomol-NT_000018
- Lopac0_000475
- Lopac0_000187
- SCHEMBL122821
- BPBio1_001177
- ZZJYIKPMDIWRSN-HWBMXIPRSA-N
- CHEBI:109533
- HMS2089C08
- ZINC2008410
- PDSP2_000547
- PDSP2_001512
- BDBM50008735
- CCG-204282
- NCGC00162085-04
- (+)-Butaclamol
- CHEBI:73298
- RefChem:67295
- (-)-Butaclamol
- Butaclamol, (+)-
- W85H7VQ3L6
- SCHEMBL29489113
- SCHEMBL29822554
- SDCCGSBI-0050175.P004
- NCGC00162085-03
- NCGC00162085-08
- NCGC00162085-09
- BRD-K20620780-001-01-0
- (+)-butaclamol
Look up BUTACLAMOL in the interactive SynDRA portal →